AbbVie
ABBV
ABBV
1,762 hedge funds and large institutions have $80.1B invested in AbbVie in 2017 Q2 according to their latest regulatory filings, with 116 funds opening new positions, 658 increasing their positions, 728 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 1,725 → 1,762 (+37)
0.78% more ownership
Funds ownership: 68.63% → 69.41% (+0.78%)
10% less repeat investments, than reductions
Existing positions increased: 658 | Existing positions reduced: 728
Holders
1,762
Holding in Top 10
118
Calls
$1.05B
Puts
$888M
Top Buyers
| 1 | +$249M | |
| 2 | +$245M | |
| 3 | +$225M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$143M |
| 5 |
BlackRock
New York
|
+$125M |
Top Sellers
| 1 | -$213M | |
| 2 | -$105M | |
| 3 | -$81.1M | |
| 4 |
GCM
Glenview Capital Management
New York
|
-$80.1M |
| 5 |
Bank of New York Mellon
New York
|
-$72.3M |